Pasitrex® Ointment 20g/0.7oz

Calcipotriol 0.005%

From USD $24.00

Pasitrex® Calcipotriol 0.005 % ointment is a synthetic vitamin D derivative used for the treatment of plaque psoriasis in adults and children above 6 years of age. It may be used alone or in a combination with other medicines.

Heximar-B® contains Calcipotriol 0.005% + Betamethasone 0.05% which is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions, including psoriasis and eczema. Betamethasone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching.

Pasitrex C® ointment contains Calcipotriol 0.005% + Clobetasol 0.05%. Pasitrex C® Ointment is used for the treatment of psoriasis and contains two medications which work together to reduce the overproduction of skin cells and also to block the production of chemical messengers which cause inflammation

Brand name: Dovone, Dovonex
Clear
TitleRangeDiscount
Items:3 - 5 5%
Items:6 - 9 10%
Items:10 + 15%

Description

What is Calcipotriol 0.005% Ointment Pasitrex®

Calcipotriene ointment Pasitrex® is manufactured by reputable Sun Pharmaceuticals. Calcipotriene aka Calcipotriol is a form of Vitamin D that treats plaque psoriasis by controlling the growth of skin cells. Calcipotriol Cream Pasitrex® is used for the treatment of psoriasis. Calcipotriol cream can be used in combinations with other medications as well. Calcipotriol Cream stops the growth of excess skin cells which is the main cause of psoriasis.

Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. These skin patches are typically red, dry, itchy, and scaly. On people with darker skin, the patches may be purple in color. Psoriasis varies in severity from small, localized patches to complete body coverage. Injury to the skin can trigger psoriatic skin changes at that spot, which is known as the Koebner phenomenon.

Pasitrex Ointment helps in treating plaque psoriasis, which is a medical condition that causes red skin patches that look like scales. The areas of the body most commonly affected by psoriasis are the knee, scalp, lower back, and elbows. The scales can prove to be extremely itchy. The condition occurs when the outer skin cells multiply at an extremely fast rate. The drug slows down the rate at which the cells multiply. Sometimes, it may be used along with another drug to fasten the process of treatment.

Brand names: Dovone, Dovonex.


How to use Calcipotriol 0.005% Ointment Pasitrex®

Pasitrex Ointment should be used precisely as per your medical adviser’s guidance. Available in the form of an ointment, Pasitrex Ointment is primarily applied twice a day. Rub in the ointment and let the skin absorb it, do not dress the affected area with a bandage as it may slow down the healing process. The solution that is meant for the scalp, should be used twice daily.

The drug can lead to irritation of the skin, which is precisely why it should be avoided on the face. Also, make sure that you wash your hands thoroughly after every application. Apart from skin irritation, Pasitrex Ointment also makes the skin more sensitive to the sun and heat. Thus, avoid going out when the sun is extremely bright or protect yourself well. Redness of the skin, a stinging sensation, and some dryness are common side effects of Pasitrex Ointment.

Information given here is based on the salt and content of the medicine. The effect and uses of medicine may vary from person to person. It is advisable to consult a Dermatologist before using this medicine.

Brand

Menarini

The Menarini Group is an Italian pharmaceutical company. Its headquarters is in Florence and has three divisions: Menarini Ricerche, Menarini Biotech and Menarini Diagnostics. It is committed to the search for pharmacological solutions for such therapeutic areas as cardiovascular diseases, oncology, pain/inflammation, asthma, and anti-infectives. Menarini's research activities are carried out through Menarini Ricerche, which deals with all R&D activities, from the creation of new projects up to the drug registration. Its Menarini Biotech follows the creation of a biotechnological drug from the very early stages of research, through to the pilot scale and up to industrial production. The Group's Menarini Diagnostics division is a health care company with a worldwide network of affiliates partners and distributors focused on diabetes, hematology, clinical chemistry, urinalysis, and immunology. In 2011, the company had 13,081 employees worldwide. Menarini India is the Indian affiliate of the Menarini Group, which is a leading biopharmaceutical company, focused on delivering differentiated ethical and consumer healthcare brands across the world. A. Menarini India operates across the entire commercial value chain, from regulatory approval and product launch to lifecycle management and offers an unparalleled customer experience to all stakeholders including partners wanting to tap into the India growth story. Through our team of over 1,200 passionate sales, marketing and support professionals, Menarini India manages a diverse portfolio of proprietary healthcare brands as well as licensed brands from global biotech and multinational companies. Leveraging the strengths of its infrastructure, Menarini India is able to tap onto extensive global resources and its' own unique local customer insights to deliver innovative brands from R&D, through to manufacturing, regulatory approvals, and commercialization. Menarini India operates in one of the fastest growing healthcare markets worldwide, increasing at an annual compounded growth rate of 15%, more than double the global growth rate for the sector. With India being among the top growth contributors globally, Menarini India is establishing itself as a leader in this rapidly expanding market through targeted investments. With over 3,300 professionals in 13 major markets, Menarini Asia-Pacific operates across the entire commercial value chain, from regulatory approval and product launch to lifecycle management and offers an unparalleled customer experience to partners wanting to tap into the Asia-Pacific growth story. To be the leading provider of important healthcare brands that improve the lives of people in the Asia-Pacific region. Menarini India continues to build its reputation as a fully integrated biopharmaceutical company based on the illustrious history and success of the Menarini Group. It operates one of the most effective and experienced professional sales and marketing organizations in the region, while practicing transparency and excellent corporate governance. Our people are our greatest assets. To encourage their best efforts, we treat each of our employees with fairness and respect, providing them with the support needed to achieve their professional goals. We believe the following four key values will be the source of our success:
  • Integrity - we do what we say, and do what is right
  • Customer Focus - we delight our customers by delivering and exceeding their expectations
  • Sense of Urgency - we value speed and despise bureaucracy
  • Ambition - we aspire to stay at the forefront of our industry by setting lofty goals

Sun Pharma

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. Sun Pharma Laboratories Limited ("SPLL" or "Company") is a pharmaceutical company having registered office in Mumbai, Maharashtra. The Company manufactures and markets pharmaceutical products in India. It was incorporated on January 17, 1997. On March 9, 2012, it became a wholly owned subsidiary of Sun Pharmaceutical Industries Limited (SPIL). SPLL is engaged in the business of manufacturing and promoting Branded Generic pharmaceutical products and has a market share of 5.6% as per AIOCD AWACS ‐October 2015. The Company has four plants located in Sikkim and Jammu. It has a strong foothold in the therapeutic segments of Neurology & Psychiatry, Central Nervous System, Cardiology, Gastroenterology, Diabetes, Gynecology etc. The Company is a market leader in India in the chronic segment, which contributes over 60% of its revenue as per AIOCD AWACS ‐October 2015. It offers a complete therapy basket with specialization in technically complex products. Among the country’s top 300 pharmaceutical brands, SPLL owns 19 brands. It has a strong field force of over 3,200 people who promote products to over 150,000 doctors across India. The field force has well-trained sales representatives with a strong track record of performance and enjoys one of the highest productivity amongst Indian pharmaceutical companies. The Company has consistently outperformed the average industry growth over years. As per February 2015 SMSRC report, the Company was ranked No.1 by prescriptions with 7 class of specialist doctors.

Additional Information

Composition

Pasitrex® Ointment 20g

Calcipotriol IP 0.005% w/w


Heximar-B® Ointment 15g

Calcipotriol IP 0.005% w/w

Betamethasone IP 0.05%  w/w


Pasitrex C® Ointment 15g

Calcipotriol IP 0.005% w/w

Clobetasol IP 0.05% w/w

Reviews

There are no reviews yet.

Be the first to review “Pasitrex® Ointment 20g/0.7oz”

Your email address will not be published. Required fields are marked *